J&J Exceeds Q2 Expectations, Oncology and Immunology Top Pharma Drivers

J&J Exceeds Q2 Expectations, Oncology and Immunology Top Pharma Drivers

Source: 
BioSpace
News Tags: 
snippet: 

Johnson & Johnson exceeded Wall Street expectations in its second quarter performance. The healthcare products giant posted sales of $25.5 billion in its earnings report on Thursday.